Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:57 PM
Ignite Modification Date:
2025-12-24 @ 6:57 PM
NCT ID:
NCT06915857
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Female.
* Histological confirmation of breast malignancy (invasive or in situ carcinoma) or phyllodes.
* Patients with large breasts \[bra size 40 in and/or D cup or greater\] and have undergone breast-conserving surgery.
* Patients are scheduled to receive conventionally- (50Gy/25#), hypo-fractionated (40Gy/15#), or extreme hypo-fractionated (26Gy/5#) photon-based radiation to whole or partial breast in prone position.
* Patients treated with or without the addition of a boost.
* Patient speaks English or can be aided by a translator.
Exclusion Criteria:
* Patients planning brachytherapy within the treatment field, and patients scheduled to receive bilateral radiation.
* Prior RT to any portion of the planned treatment site.
* Active rash or pre-existing dermatitis within the treatment field.
* Concomitant cytotoxic chemotherapy.
* Unable to tolerate RT in prone.
* Treatment involves use of tissue equivalent bolus.
* Known sensitivity or allergy to betamethasone.
* Known pregnancy.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06915857
Study Brief:
Protocol Section:
NCT06915857